Best of Oncology Podcast Series

263 Episodes

1. ASH HIGHLIGHTS 2023 – LYMPHOMA ROUNDTABLE DISCUSSION: Clinical Characteristics And Outcomes Of MYC And DHL-BCL6 With Other Aggressive B-Cell Lymphomas

   Published: 18/12/2023
2. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Clonal Hematopoiesis Mutations Detected at the Time of Stopping Tyrosine Kinase Inhibitor Therapy

   Published: 15/12/2023
3. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Results from the ALLG CML13 Ascend-CML Study

   Published: 15/12/2023
4. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: TIPI in the Front-Line Treatment of CP CML Setting

   Published: 15/12/2023
5. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: ABL001 In Combination With Dasatinib And Prednisone For BCR-ABL1-Positive ALL And Blast Phase CML In Adults

   Published: 15/12/2023
6. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Preliminary Results of the GMALL Bold Trial

   Published: 15/12/2023
7. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Final Results of the Phase II Gimema LAL2317 Trial

   Published: 15/12/2023
8. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Results of the Graall-2014/T Atriall Phase 2 Study

   Published: 15/12/2023
9. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Analysis of the UK NCRI AML17 and AML19 Studies

   Published: 15/12/2023
10. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Venetoclax Combined with Decitabine Versus Conventional Chemotherapy As Induction Therapy for Young Adults

    Published: 15/12/2023
11. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Fully Oral Combination of ASTX727 Plus Venetoclax for Older and/or Unfit Patients with AML

    Published: 15/12/2023
12. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Quantum-First Trial

    Published: 15/12/2023
13. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Results from the NCRI AML18 Randomised Trial

    Published: 15/12/2023
14. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: CD33CART For Children And Young Adults With Relapsed/Refractory AML

    Published: 15/12/2023
15. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: Quizartinib, Venetoclax, and Decitabine Triple Combination in FLT3-ITD Mutated AML

    Published: 15/12/2023
16. ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: All-Oral Combination SNDX-5613 With ASTX727 Venetoclax In AML

    Published: 15/12/2023
17. BEST OF ONCOLOGY EAST CONFERENCE 2023: Breast Cancer – Dr. Nazik Hammad

    Published: 7/12/2023
18. BEST OF ONCOLOGY EAST CONFERENCE 2023: Melanoma – Dr. Rossanna Pezo

    Published: 7/12/2023
19. BEST OF ONCOLOGY EAST CONFERENCE 2023: Special Session: Survivorship – Dr. Jennifer Jones

    Published: 7/12/2023
20. BEST OF ONCOLOGY EAST CONFERENCE 2023: Non-Prostate Cancer – Dr. Aly-Khan Lalani

    Published: 7/12/2023